EA201490875A1 - Производное аминоалкилзамещенного n-тиенилбензамида - Google Patents

Производное аминоалкилзамещенного n-тиенилбензамида

Info

Publication number
EA201490875A1
EA201490875A1 EA201490875A EA201490875A EA201490875A1 EA 201490875 A1 EA201490875 A1 EA 201490875A1 EA 201490875 A EA201490875 A EA 201490875A EA 201490875 A EA201490875 A EA 201490875A EA 201490875 A1 EA201490875 A1 EA 201490875A1
Authority
EA
Eurasian Patent Office
Prior art keywords
npt
derivative
agent
iib
present
Prior art date
Application number
EA201490875A
Other languages
English (en)
Other versions
EA023955B1 (ru
Inventor
Масанори Миура
Дайсуке Кага
Сусуму Ватануки
Сунитиро Хатия
Такао Окуда
Иппеи Сато
Маи Исомура
Казухиро Тераи
Йох Терада
Original Assignee
Астеллас Фарма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астеллас Фарма Инк. filed Critical Астеллас Фарма Инк.
Publication of EA201490875A1 publication Critical patent/EA201490875A1/ru
Publication of EA023955B1 publication Critical patent/EA023955B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80—Seven-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Abstract

Проблема: предоставление соединения, которое обладает действием по ингибированию переносчика кишечного фосфата (NPT-IIb) и является применимым в качестве активного ингредиента агента для лечения и/или предупреждения гиперфосфатемии. Способы разрешения проблемы: авторы настоящего изобретения провели исследования в отношении соединения, которое обладает ингибирующим NPT-IIb действием и является применимым в качестве активного ингредиента агента для лечения и/или предупреждения гиперфосфатемии. В результате они разработали производное аминоалкилзамещенного N-тиенилбензамида, которое обладает ингибирующим NPT-IIb действием, тем самым завершив настоящее изобретение. Производное аминоалкилзамещенного N-тиенилбензамида настоящего изобретения обладает ингибирующим NPT-IIb действием, и его можно применять в качестве агента для предупреждения или лечения гиперфосфатемии.
EA201490875A 2011-10-27 2012-10-25 Производное аминоалкилзамещенного n-тиенилбензамида EA023955B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011236533 2011-10-27
PCT/JP2012/077660 WO2013062065A1 (ja) 2011-10-27 2012-10-25 アミノアルキル置換n-チエニルベンズアミド誘導体

Publications (2)

Publication Number Publication Date
EA201490875A1 true EA201490875A1 (ru) 2014-09-30
EA023955B1 EA023955B1 (ru) 2016-07-29

Family

ID=48167891

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490875A EA023955B1 (ru) 2011-10-27 2012-10-25 Производное аминоалкилзамещенного n-тиенилбензамида

Country Status (16)

Country Link
US (1) US9062032B2 (ru)
EP (1) EP2772490B1 (ru)
JP (2) JP6020460B2 (ru)
KR (1) KR101941048B1 (ru)
CN (1) CN103906741B (ru)
AR (1) AR088563A1 (ru)
AU (1) AU2012329913A1 (ru)
CA (1) CA2853688C (ru)
EA (1) EA023955B1 (ru)
ES (1) ES2585415T3 (ru)
IL (1) IL232230A0 (ru)
IN (1) IN2014CN03130A (ru)
MX (1) MX342521B (ru)
PL (1) PL2772490T3 (ru)
TW (1) TW201323419A (ru)
WO (1) WO2013062065A1 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20150043A2 (ru) 2012-10-02 2015-08-31 Epitherapeutics Aps Ингибиторы гистон деметилаз
US9499553B2 (en) 2013-03-13 2016-11-22 Chugai Seiyaku Kabushiki Kaisha Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same
PL2975030T3 (pl) 2013-03-13 2021-01-11 Chugai Seiyaku Kabushiki Kaisha Pochodna dihydropirydazyno-3,5-dionu
TWI594975B (zh) * 2013-04-24 2017-08-11 第一三共股份有限公司 二羧酸化合物
SG11201600891UA (en) 2013-08-08 2016-03-30 Galapagos Nv Thieno[2,3-c]pyrans as cftr modulators
WO2015064532A1 (ja) * 2013-10-30 2015-05-07 第一三共株式会社 モルホリン化合物
WO2015153498A1 (en) * 2014-03-31 2015-10-08 Epitherapeutics, Aps Inhibitors of histone demethylases
CN105658635B (zh) * 2014-08-22 2019-03-08 江苏恒瑞医药股份有限公司 噻吩并环烷基或噻吩并杂环基类衍生物、其制备方法及其在医药上的应用
EP3192511B1 (en) 2014-09-12 2021-07-14 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical containing sodium-dependent phosphate transporter inhibitor
CA2962724C (en) 2014-09-26 2019-11-19 Daiichi Sankyo Company, Limited Salt of dicarboxylic acid compound
CN105524053B (zh) * 2014-10-19 2020-06-05 广东东阳光药业有限公司 四氢苯并噻吩化合物
TW201700458A (zh) 2015-04-24 2017-01-01 第一三共股份有限公司 二羧酸化合物之製法
CN107082773B (zh) * 2016-02-16 2020-07-28 江苏恒瑞医药股份有限公司 一种肠2b型磷酸钠协同转运蛋白抑制剂的硫酸盐及其结晶形式
JP6653410B2 (ja) * 2016-08-15 2020-02-26 イーライ リリー アンド カンパニー ＮａＰｉ−ＩＩｂ阻害剤として有用な縮合チオフェン誘導体
JOP20190080A1 (ar) 2016-10-14 2019-04-11 Bayer Pharma AG مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها
CN109422723B (zh) * 2017-08-25 2021-02-23 江苏恒瑞医药股份有限公司 一种肠2b型磷酸钠协同转运蛋白抑制剂的晶型及其制备方法
IL309056A (en) 2021-06-08 2024-02-01 Chugai Pharmaceutical Co Ltd A preparation containing a DIHYDROPYRIDAZINE-3,5-DIONE derivative
AR126060A1 (es) 2021-06-08 2023-09-06 Chugai Pharmaceutical Co Ltd Método para producir derivado de dihidropiridazin-3,5-diona
WO2023203254A2 (en) 2022-04-22 2023-10-26 Fundamental Pharma Gmbh Effective means to modulate nmda receptor-mediated toxicity

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002028353A2 (en) * 2000-10-05 2002-04-11 Smithkline Beecham Corporation Phosphate transport inhibitors
JP2007131532A (ja) 2001-09-28 2007-05-31 Kirin Brewery Co Ltd 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
AU2002354410A1 (en) 2001-12-05 2003-06-17 Japan Tobacco Inc. Triazole compound and medicinal use thereof
US8134015B2 (en) 2003-03-27 2012-03-13 Kyowa Hakko Kirin Co., Ltd. Compound inhibiting in vivo phosphorous transport and medicine containing the same
WO2006093518A2 (en) * 2004-06-25 2006-09-08 Apath, Llc Thienyl compounds for treating virus-related conditions
AU2005279845A1 (en) 2004-08-30 2006-03-09 Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Inhibition of viruses using RNase H inhibitors
EP1802634A2 (en) 2004-10-20 2007-07-04 Compass Pharmaceuticals LLC Thiophens and their use as anti-tumor agents
NZ586094A (en) * 2008-01-08 2012-06-29 Purdue Pharma Lp Proline analogs as ligands for cannabinoid receptors for the treatment of pain
EP2565190B1 (en) 2010-04-28 2015-06-03 Astellas Pharma Inc. Tetrahydrobenzothiophene compound
EP2591354B1 (en) 2010-07-07 2016-09-07 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012006477A1 (en) 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012054110A2 (en) 2010-07-07 2012-04-26 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP2590965B1 (en) 2010-07-07 2016-04-20 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012006473A1 (en) 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport

Also Published As

Publication number Publication date
PL2772490T3 (pl) 2016-11-30
CA2853688C (en) 2018-06-12
CA2853688A1 (en) 2013-05-02
ES2585415T3 (es) 2016-10-05
BR112014010169A2 (pt) 2017-04-25
KR101941048B1 (ko) 2019-01-22
IN2014CN03130A (ru) 2015-07-03
MX342521B (es) 2016-10-03
JP2013107880A (ja) 2013-06-06
EP2772490A4 (en) 2015-01-21
EP2772490A1 (en) 2014-09-03
US9062032B2 (en) 2015-06-23
MX2014005090A (es) 2015-02-12
EA023955B1 (ru) 2016-07-29
EP2772490B1 (en) 2016-04-06
KR20140096322A (ko) 2014-08-05
JP6020460B2 (ja) 2016-11-02
CN103906741A (zh) 2014-07-02
JPWO2013062065A1 (ja) 2015-04-02
AU2012329913A1 (en) 2014-05-22
CN103906741B (zh) 2016-01-20
WO2013062065A1 (ja) 2013-05-02
US20150031727A1 (en) 2015-01-29
AR088563A1 (es) 2014-06-18
IL232230A0 (en) 2014-06-30
TW201323419A (zh) 2013-06-16

Similar Documents

Publication Publication Date Title
EA201490875A1 (ru) Производное аминоалкилзамещенного n-тиенилбензамида
EA201890308A1 (ru) Замещенные азасоединения как ингибиторы irak-4
MX2017012729A (es) Inhibidores de indolamina 2,3-dioxigenasa (ido) para el tratamiento de cancer.
CY1122305T1 (el) Ενωσεις υδροξαζολης υδροξαμικου οξεος ως αναστολεις lpxc
CY1122805T1 (el) Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων
EA201690753A1 (ru) Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
EA201691354A1 (ru) Терапевтические ингибирующие соединения
WO2015168466A8 (en) Inhibitors of lysine specific demethylase-1
EA201790108A1 (ru) Гетероарильные соединения, пригодные в качестве ингибиторов sumo-активирующего фермента
EA201690027A1 (ru) Ингибиторы ido
EA201691803A1 (ru) Ингибиторы калликреина плазмы человека
BR112015032710A2 (pt) inibidores de bromodomínio
EA201690306A1 (ru) Ингибиторы ido
BR112012025390A2 (pt) composto de tetraidrobenzotiofeno
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
EA201692506A3 (ru) Ингибиторы репликации вирусов гриппа
MX2020001757A (es) Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades.
TR201905233T4 (tr) Dirençli bakteriyel enfeksiyonların tedavisine yönelik kombinasyon tedavisi.
MY195675A (en) A Group of Compounds used for the Treatment or Prevention of Hyperuricemia or Gout
EA201492279A1 (ru) Лекарственное средство для предупреждения и/или лечения поликистозной болезни почек
EA201491500A1 (ru) Способы лечения фиброза
TN2017000510A1 (en) Use of benzimidazole derivatives for nocturnal acid breakthrough.
EA201790276A1 (ru) Новые имидазопиридазиновые соединения и их применение
EA201690227A1 (ru) Азаиндольные соединения, их получение и способы их применения
MX2022006229A (es) Composiciones y metodos para el tratamiento de resistencia a la insulina.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM